Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 8, 2007, Pages 1952-1965

  Arispe, Nelson ^a   Diaz, Juan C ^a   Simakova, Olga ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA CHANNEL BLOCKER; AMYLOID BETA PROTEIN; BLOCKING AGENT; CALCIUM CHANNEL; ION CHANNEL; LIPOSOME; MEMBRANE RECEPTOR; PEPTIDE NA3; PEPTIDE NA7; UNCLASSIFIED DRUG; AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT; CYTOTOXIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTIFICIAL MEMBRANE; CELL MEMBRANE; CYTOTOXICITY; HUMAN; LIPID BILAYER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; ANIMAL; BRAIN; CHEMISTRY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ION TRANSPORT; METABOLISM; PATHOLOGY;

ANIMALIA;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BRAIN; CELL MEMBRANE; CYTOTOXINS; DISEASE MODELS, ANIMAL; HUMANS; ION CHANNELS; ION TRANSPORT; MEMBRANE TRANSPORT MODULATORS; MEMBRANES, ARTIFICIAL;

EID: 34547214510     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.03.014     Document Type: Review

References (111)

1. Arispe N., Rojas E., and Pollard H.B. Alzheimer disease amyloid β-protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 567-571
2. Mattson M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77 (1997) 1081-1132
3. Haass C., Schlossmacher M., Hung A.Y., et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
4. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., and Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391 6665 (1998) 339-340
5. Haass C., and Selkoe D. A technical KO of amyloid-β peptide. Nature 391 6665 (1998) 339-340
6. Yankner B.A. Mechanism of neuronal degeneration in Alzheimer's disease. Review. Neuron 16 (1996) 921-932
7. Yankner B.A. The pathogenesis of Alzheimer's disease. Is amyloid beta-protein the beginning or the end?. Ann. N. Y. Acad. Sci. 924 (2000) 26-28
8. Hardy J.A., and Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 5054 (1992) 184-185
9. Hardy J.A., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 5580 (2002) 353-356
10. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., and Neve R.L. Neurotoxicity of a fragment of the amyloid precursor protein associated with Alzheimer's disease. Science 245 (1989) 417-429
11. Wisniewski T., Ghiso J., and Frangione B. Biology of Aβ amyloid in Alzheimer's disease. Neurobiol. Dis. 4 (1997) 311-328
12. Seubert P., Vigo-Pelfrey C., Esch F., et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359 (1992) 325-327
13. Shoji M., Golde T.E., Ghiso J., et al. Production of the Alzheimer amyloid β-protein by normal proteolytic processing. Science 258 (1992) 126-129
14. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., and Rogers J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155 (1999) 853-862
15. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., and Buxbaum J.D. Correlation between elevated levels of amyloid-β-peptide in the brain and cognitive decline. JAMA 283 (2000) 1571-1577
16. Koistinaho M., Ort M., Cimadevilla J.M., Vondrous R., Cordell B., Koistinaho J., et al. Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques. Proc. Natl. Acad. Sci. U. S. A. 98 25 (2001) 14675-14680
17. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L., Carlson G.A., Younkin S.G., and Ashe K.H. The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22 5 (2002) 1858-1867
18. 2+-channel hypothesis for neuronal death in Alzheimer disease. Mol. Cell. Biochem. 140 (1994) 19-125
19. 2+ channels provides a mechanism for neuronal death in Alzheimer's disease. Ann. N.Y. Acad. Sci. 747 (1994) 256-266
20. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Membr. Biol. 280 17 (2005) 17294-17300
21. Mattson M.P., Cheng B., Davis D., Bryant K., Liberberg I., and Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
22. Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., and Rydel R.E. β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16 (1993) 409-415
23. Kawahara M., Kuroda Y., Arispe N., and Rojas E. Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275 19 (2000) 14077-14083
24. Kawahara M. Disruption of calcium homeostasis in the pathogenesis of Alzheimer's disease and other conformational diseases. Curr. Alzheimer Res. 1 (2004) 87-95
25. Bhathia R., Lin H., and Lal R. Fresh and globular amyloid b protein induces rapid cellular degeneration. A possible implication for calcium-uptake via AβP-channel. FASEB J. 14 9 (2000) 1233-1243
26. Zhu Y.J., Lin H., and Lal R. Fresh and nonfibrillar amyloid β protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for A(P-channel-mediated cellular toxicity. FASEB J. 14 9 (2000) 1244-1254
27. Lin H., Bhatia R., and Lal R. Amyloid protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15 (2001) 2433-2444
28. LaFerla F.M. Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat. Rev., Neurosci. 3 (2002) 862-872
29. Smith I.F., Green K.N., and LaFerla F.M. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 38 (2005) 427-437
30. Ye C., Ho-Poo C.L., Kanazirska M., Quinn S., Rogers K., Seidman C.E., and Brown E.M. Amyloid beta proteins activate Ca(2+)-permeable channels through calcium-sensing receptors. J. Neurosci. Res. 47 (1987) 547-554
31. Koh J.-Y., Yang L.L., and Cotman C.W. β-Amyloid increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533 (1990) 315-320
32. Kayed R., Sokolov Y., Edmonds B., McIntire T.M., Milton S.C., Hall J.E., and Glabe C.G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279 45 (2004) 46363-46366
33. Verdier Y., and Penke B. Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease. Curr. Protein Pept. Sci. 5 1 (2004) 19-31 (Review)
34. Verdier Y., Zarandi M., and Penke B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci. 10 5 (2004) 229-248 (Review)
35. Yankner B.A., Duffy L.K., and Kirschner D.A. Neurotropic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250 (1990) 279-282
36. Shearman M.S. Cellular MTT reduction distinguishes the mechanism of action of beta-amyloid from that of tachykini receptor peptides. Neuropeptides 30 (1996) 125-132
37. Joslin G., Krause J.E., Hershey A.D., Adams S.P., Fallon R.J., and Perlmutter D.H. Amyloid-β-peptide, substance P and bombesin bind to the serpin-enzyme complex receptor. J. Biol. Chem. 266 (1991) 21897-21902
38. Boland K., Behrens M., Choi D., Manias K., and Perlmutter D.H. The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta-peptide but not aggregated cytotoxic amyloid-beta-peptide. J. Biol. Chem. 271 (1996) 18032-18044
39. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
40. Liu Y., Dargusch R., and Schubert D. Beta amyloid toxicity does not require RAGE protein. Biochem. Biophys. Res. Commun. 237 1 (1997) 37-40
41. Whitson J.S., and Appel S.H. Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade. Neurobiol. Aging 16 (1995) 5-10
42. 2+ channel activity by β-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. J. Biol. Chem. 275 (2000) 4713-4718
43. McLaurin J., Franklin T., Fraser P.E., and Chakrabartty A. Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides. J. Biol. Chem. 273 8 (1998) 4506-4515
44. Sokolov Y., Kozak J.A., Kayed R., Chanturiya A., Glabe C., and Hall J.E. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J. Gen. Physiol. 128 (2006) 637-647
45. Arispe N., Rojas E., and Pollard H.B. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10573-10577
46. Kagan B.L., Hirakura Y., Azimov R., Azimova R., and Lin M.-C. The channel hypothesis of Alzheimer's disease: current status. Peptides 23 (2002) 1311-1315
47. Vargas J., Alarcon J.M., and Rojas E. Displacement currents associated with the insertion of Alzheimer disease amyloid β-peptide into planar bilayer membranes. Biophys. J. 79 (2000) 934-944
48. Lau T.L., Ambroggio E.E., Tew D.J., Cappai R., Masters C.L., Fidelio G.D., Barnham K.J., and Separovic F. Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions. J. Mol. Biol. 356 3 (2006) 759-770
49. Mobley D.L., Cox D.L., Singh R.R.P., Maddox M.W., and Longo M.L. Modeling amyloid β-peptide insertion into lipid bilayers. Biophys. J. 86 (2004) 3585-3597
50. Terzi E., Holzemann G., and Seelig J. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252 5 (1995) 633-642
51. Terzi E., Holzemann G., and Seelig J. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. Biochemistry 36 48 (1997) 14845-14852
52. Alarcon J.M., Brito J.A., Hermosilla T., Atwater I., Mears D., and Rojas E. Ion channel formation by Alzheimer's disease amyloid β-peptide (Aβ40) in unilamellar liposomes is determined by anionic phospholipids. Peptides 27 (2006) 95-104
53. Hertel C., Terzi E., Hauser N., Jakob-Rotne R., Seelig J., and Kemp J.A. Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc. Natl. Acad. Sci. U. S. A. 94 17 (1997) 9412-9416
54. McLaurin J., and Chakrabartty A. Characterization of the interactions of Alzheimer beta amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245 (1997) 355-363
55. Chauhan A., Ray I., and Chauhan V.P. Interaction of amyloid beta-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids. Neurochem. Res. 25 3 (2000) 423-429
56. Bokvist M., Lindstrom F., Watts A., and Grobner G. Two types of Alzheimer's b-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335 (2004) 1039-1049
57. Lee G., Pollard H.B., and Arispe N. Annexin 5 and apolipoprotein E2 protect against Alzheimer's Amyloid β Peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site. Peptides 23 (2002) 1249-1263
58. Zhao H., Tuominen E.K., and Kinnunen P.K. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry 43 32 (2004) 10302-10307
59. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., and Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276 27 (2001) 24985-24990
60. Wakabayashi M., Okada T., Kozutsumi Y., and Matsuzaki K. GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes. Biochem. Biophys. Res. Commun. 328 (2005) 1019-1023
61. Yanagisawa K., Odaka A., Suzuki N., and Ihara Y. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1 10 (1995) 1062-1066
62. Yanagisawa K. GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloid. Neuroscientist 11 3 (2005) 250-260
63. Ji S.R., Wu Y., and Sui S.F. Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277 8 (2002) 6273-6279
64. Tashima Y., Oe R., Lee S., Sugihara G., Chambers E.J., Takahashi M., and Yamada T. The effect of cholesterol and monosialoganglioside (GM1) on the release and aggregation of amyloid β-peptide from liposomes prepared from brain membrane-like lipids. J. Biol. Chem. 279 17 (2004) 17587-17595
65. Choo-Smith L.-P., and Surewicz W.K. The interaction between Alzheimer amyloid beta (1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402 (1997) 95-98
66. Yanagisawa K., and Matsuzaki K. Cholesterol-dependent aggregation of amyloid beta-protein. Ann. N. Y. Acad. Sci. 977 (2002) 384-386
67. Kakio A., Yano Y., Takai D., Kuroda Y., Matsumoto O., Kozutsumi Y., and Matsuzaki K. Interaction between amyloid β-protein aggregates and membranes. J. Pept. Sci. 10 10 (2004) 612-621
68. Durrell S.R., Guy H.R., Arispe N., Rojas E., and Pollard H.B. Theoretical models of the ion channel structure of amyloid-β-protein. Biophys. J. 67 (1994) 2137-2145
69. Arispe N.J. Architecture of the Alzheimer's AβP ion channel. J. Membr. Biol. 197 1 (2004) 33-48
70. 2+ interaction with Alzheimer amyloid β protein calcium channels. Proc. Natl. Acad. Sci. 93 (1996) 1710-1715
71. Pollard H.B., Arispe N., and Rojas E. Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity. Cell. Mol. Neurobiol. 15 5 (1995) 513-526
72. Guy H.R., and Conti F. Pursuing the structure and function of voltage-gated channels. Trends Neurosci. 13 6 (1990) 201-206
73. Durell S.R., Raghunathan G., and Guy H.R. Modeling ion channel structure of cepropin. Biophys. J. 63 (1992) 1623-1631
74. Pollard H.B., and Rojas E. Ca2+-activated synexin forms highly selective, voltage-gated Ca2+ channels in phosphatidylserine bilayer membranes. Proc. Natl. Acad. Sci. U. S. A. 85 9 (1988) 2974-2978
75. Pollard H.B., Burns A.L., and Rojas E. Synexin (annexin VII): a cytosolic calcium-binding protein which promotes membrane fusion and forms calcium channels in artificial bilayer and natural membranes. J. Membr. Biol. 117 2 (1990) 101-112
76. Pollard H.B., Rojas E., Pastor R.W., Rojas E.M., Guy H.R., and Burns A.L. Synexin. Molecular mechanism of calcium-dependent membrane fusion and voltage-dependent calcium-channel activity. Evidence in support of the "hydrophobic bridge hypothesis" for exocytotic membrane fusion. Ann. N. Y. Acad. Sci. 635 (1991) 328-351
77. Pollard H.B., Guy H.R., Arispe N., de la Fuente M., Lee G., Rojas E.M., Pollard J.R., Srivastava M., Zhang-Keck Z.Y., and Merezhinskaya N. Calcium channel and membrane fusion activity of synexin and other members of the Annexin gene family. Biophys. J. 62 1 (1992) 15-18
78. Rojas E., Pollard H.B., Haigler H.T., Parra C., and Burns A.L. Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes. J. Biol. Chem. 265 34 (1990) 21207-21215
79. Rojas E., Arispe N., Haigler H.T., Burns A.L., and Pollard H.B. Identification of annexins as calcium channels in biological membranes. Bone Miner. 17 2 (1992) 214-218
80. Arispe N., Rojas E., Genge B.R., Wu L.N., and Wuthier R.E. Similarity in calcium channel activity of annexin V and matrix vesicles in planar lipid bilayers. Biophys. J. 71 4 (1996) 1764-1775
81. Hirakura Y., Lin M.C., and Kagan B.L. Alzheimer amyloid beta peptide 1-42 channels: effect of solvent, pH, and congo red. J. Neurosci. Res. 57 (1999) 458-460
82. Kourie J.I., Henry C.L., and Farrelly P. Diversity of amyloid beta protein fragment [1-40] -formed channels. Cell. Mol. Neurobiol. 3 (2001) 255-284
83. Micelli S., Meleleo D., Picciarelli V., and Gallucci E. Effects of sterols on β-amyloid peptide (AβP 1-40) channel formation and their properties in planar lipid membranes. Biophys. J. 86 (2004) 2231-2237
84. 2+-sensitive cation-selective channels across excited membrane patches from hypothalamic neurons. Biophys. J. 73 (1997) 67-75
85. 2+ sensitive channels. J. Biol. Chem. 273 (1998) 13379-13382
86. 2+ sensitive channels in reconstituted lipid vesicles. Biochemistry 38 (1999) 11189-11196
87. Evans E., and Needham D. Physical properties of surfactant bilayer membranes: thermal transitions, elasticity, rigidity, cohesion and colloidal interactions. J. Phys. Chem. 91 (1987) 4219-4228
88. Ambroggio E.E., Kim D.H., Separovic F., Barrow C.J., Barnham K.J., Bagatolli L.A., and Fidelio G.D. Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys. J. 88 4 (2005) 2706-2713
89. Taylor S.C., Batten T.C., and Peers C. Hypoxic enhancement of quantal catecholamine secretion. Evidence for the involvement of amyloid beta-peptides. J. Biol. Chem. 274 44 (1999) 31217-31222
90. Green K.N., and Peers C. Amyloid beta peptides mediate hypoxic augmentation of Ca(2+) channels. J. Neurochem. 77 3 (2001) 953-956
91. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
92. Simakova O., and Arispe N. Early and late cytotoxic effects of external application of the Alzheimer's Aβ result from the initial formation and function of ion channels. Biochemistry 45 (2006) 5907-5915
93. Diaz J.C., Linnehan J., Pollard H., and Arispe N. Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity. Biol. Res. 39 (2006) 447-460
94. Loo D.T., Copani A., Pike C.J., Whittemore R.E., Walencewicz A.J., and Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7951-7955
95. Su J.H., Anderson A.J., Cummings B.J., and Cotman C.W. Immuno-histochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 5 (1994) 2529-2533
96. Su J.H., Zhao M., Anderson A.J., Srinivasan A., and Cotman C.W. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res. 898 2 (2001) 350-357
97. Allen J.W., Eldabah B.A., Huang X., Knoblach S.M., and Faden A.I. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J. Neurosci. Res. 65 (2001) 45-53
98. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., and Greenberg M.E. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. 21 19 (2001) 7551-7560
99. Simmons M.A., and Schneider C.R. Amyloid β peptides act directly on single neurons. Neurosci. Lett. 150 (1993) 133-136
100. Galdzicki Z., Fukuyama R., Wadhwani K., Rapoport S., and Ehrenstein G. β-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease. Brain Res. 646 (1994) 332-336
101. Mirzabekov T., Lin M.C., Yuan W.L., Marshall P.J., Carman M., Tomaselli K., Lieberburg I., and Kagan B.L. Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem. Biophys. Res. Commun. 202 (1994) 1142-1148
102. Furukawa K., Abe Y., and Akaike N. Amyloid β protein-induced irreversible current in rat cortical neurones. NeuroReport 5 (1994) 2016-2018
103. Hirakura Y., Yiu W.W., Yamamoto A., and Kagan B.L. Amyloid peptide channels: blockade by zinc and inhibition by Congo red. Amyloid 7 (2000) 194-199
104. Lin M.-C., and Kagan B. Electrophysiologic properties of channels induced by Aβ25-35 in planar lipid bilayers. Peptides 23 7 (2002) 1215-1228
105. Bahadi R., Farrelly P.V., Kenna B.L., Curtain C.C., Masters C.L., Cappai R., Barnham K.J., and Kourie J.I. Cu2+-induced modification of the kinetics of A beta(1-42) channels. Am. J. Physiol., Cell Physiol. 285 4 (2003) C873-C880
106. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J., and Lal R. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U. S. A. 102 30 (2005) 10427-10432
107. Gandy S. The role of cerebral amyloid B accumulation in common forms of Alzheimer disease. J. Clin. Invest. 115 5 (2005) 1121-1129
108. S. Gandy, F.L. Heppner, Alzheimer's amyloid immunotherapy: quo vadis? http://neurology.thelancet.com vol. 4 (2005) 452-453.
109. Gandy S., and Heppner F.L. Breaking up (amyloid) is hard to do. PLoS Med. 2 12 (2005) e417
110. Jankowsky J.L., Slunt H.H., Gonzalez V., Savonenko A.V., Wen J.C., et al. Persistent amyloidosis following suppression of Aβ production in a transgenic model of Alzheimer disease. PLoS Med. 2 12 (2005) e355
111. Geula C., Wu C.K., Saroff D., Lorenzo A., Yuan M., and Yankner B.A. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat. Med. 4 7 (1998) 827-831